Bridger practises in the area of intellectual property law. In addition to
being a lawyer, Irene is a registered patent agent in both Canada and the
United States and a registered trademark agent in Canada.
includes intellectual property litigation, protection and enforcement of
intellectual property rights, and commercialization of intellectual property.
Irene practices before Federal and Alberta courts in matters related to
patents, trademarks and copyright. In addition, she is involved in the
preparation and prosecution of patent applications dealing with a variety of
technologies. Irene has also been involved in negotiating and drafting
technology licensing, research and joint venture agreements.
Irene has a
scientific background that includes a Ph.D. in microbiology and time spent as a
post-doctoral fellow at the Rockefeller University in New York, working with
Nobel Laureate Dr. Gunter Blobel.
- Novopharm, with respect to the Federal Court judgment in favour of Novopharm against Pfizer. Novopharm was seeking to market a generic version of CELEBREX. Novopharm's allegation that Searle's patent was invalid was held to be justified. G.D. Searle & Co. v. Novopharm Limited, 2007 FCA 173
2017, The Canadian Legal Lexpert Directory
Irene T. Bridger, repeatedly recommended, Intellectual Property
2016, IAM Patent 1000 The World's Leading Patent Practitioners
Irene T. Bridger, recommended as a leading patent professional in the category of prosecution
2014, Lexpert/Report on Business Special Edition - Canada's Leading Energy Lawyers
Irene T. Bridger, recognized as a leading energy lawyer in Canada
News & Speaking Engagements